NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
Curis Lifesciences

Curis Lifesciences

Open Date

07 Nov 2025

Close Date

11 Nov 2025

listed

Min Investment

₹256000

Lot Size

2000 Shares

Issue Size

₹27.52 Cr

Price Range

₹120 - ₹128

Listing Date

Nov 14, 2025

IPO Doc

RHP PDF

About Curis Lifesciences

Established in 2010, Curis Lifesciences Limited is a pharmaceutical company specializing in the development, manufacturing, and distribution of a diverse range of products.The company manufactures pharmaceutical products both internationally and nationally on a loan license or on a contract basis, and for own brand marketing.The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya.Curis Lifesciences specializes in the development, manufacturing, and distribution of a broad array of pharmaceutical products that include:General pharmaceutical tablets and capsulesOral liquidsExternal preparationsSterile ophthalmic ointmentsThe firm has a state-of-the-art manufacturing facility in Sanand, Gujarat, operating under strict quality control measures to ensure the safety and efficacy of its products.The company offers different pharmaceutical formulations and products made on a contract basis.They provide tablets, capsules, external preparations, oral liquids, and sterile ophthalmic ointments. As of June 30, 2024, the company has 93 permanent employees.

Checklist Quality Analysis

Revenue Growth

Company Valuation

Earning Expansion

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily.

8(+6.25%)GMP
6.25%Prediction Listing Gain

Curis Lifesciences IPO - Issue Objectives

₹2.44 crore for manufacturing facility upgrades and ₹3.62 crore for storage facility construction. The company will use ₹1.86 crore towards repayment of outstanding secured loans. ₹2.69 crore will be used towards product registrations in other countries Curis Lifesciences will use ₹11.25 crore to fund working capital requirements. Part of the IPO proceeds will be used for general corporate purposes

Capital Expenditure

22.02%

Repayment of loans

6.76%

Product registrations

9.77%

Working capital

40.87%

General corporate purposes

20.65%

1

Capital Expenditure

₹2.44 crore for manufacturing facility upgrades and ₹3.62 crore for storage facility construction.

22.02%
2

Repayment of loans

The company will use ₹1.86 crore towards repayment of outstanding secured loans.

6.76%
3

Product registrations

₹2.69 crore will be used towards product registrations in other countries

9.77%
4

Working capital

Curis Lifesciences will use ₹11.25 crore to fund working capital requirements.

40.87%
5

General corporate purposes

Part of the IPO proceeds will be used for general corporate purposes

20.65%

IPO Subscription Status

Retails
21.88x
QIB
0.00x
NII
25.03x

Financials of Curis Lifesciences

In Cr.

Revenue: ₹36.91

EBITDA: ₹8.89

Profit: ₹5.30

Total Income
EBITDA
Total Profit
Negative Value
Key Performance Indicator31-Dec-24 (In Cr.)31-Mar-24 (In Cr.)31-Mar-23 (In Cr.)31-Mar-22 (In Cr.)
Revenue36.9135.8936.3923.76
EBITDA8.898.413.253.58
Expenses
Profit After Tax5.305.031.850.49
Assets50.1233.8229.6727.40
Net Worth15.535.970.950.90
Reserves9.595.470.45-1.40
Borrowing16.1617.0916.1917.62

Curis Lifesciences - Promoter(s)

Curis Lifesciences

Dharmesh Dashrathbhai Patel Mr

Siddhant Jayantibhai Pawasia Mr

Piyush Gordhanbhai Antala Mr

Pre Issue Share Holding

N/A

Post Issue Share Holding

N/A

Registrar Contact Details

MUFG Intime India Pvt.Ltd.

PF-23, GIDC Sanand - II, Industrial Estate, Sanand, Ahmedabad, Gujarat, 382110

Curis Lifesciences IPO - FAQs

Curis Lifesciences IPO is a SME IPO. The issue is priced at ₹120-128 per equity share. The minimum order quantity is 2000 Shares. The IPO opens on 7 Nov, and closes on 11 Nov. MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on SME.

Live IPOs

CMR Green Technologies logo

CMR Green Technologies

Mainboard
BSE
NSE
Open  Close3rd Jun 2026 - 5th Jun 2026
Issue Size630.88 Cr
Min. Qty78 Shares
Issue Price₹ 182.00
Live IPO
Vahh Chemicals logo

Vahh Chemicals

SME
Open  Close4th Jun 2026 - 8th Jun 2026
Issue Size13.45 Cr
Min. Qty2000 Shares
Issue Price₹ 60.00
Live IPO
UHM Vacation logo

UHM Vacation

SME
Open  Close4th Jun 2026 - 8th Jun 2026
Issue Size36.02 Cr
Min. Qty800 Shares
Issue Price₹ 157.00
Live IPO
Hexagon Nutrition logo

Hexagon Nutrition

Mainboard
Open  Close5th Jun 2026 - 9th Jun 2026
Issue Size138.87 Cr
Min. Qty333 Shares
Issue Price₹ 42.00
Live IPO
See All Live IPOs
IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.